Outpatient medical abortion is safe and effective through 70 days gestation

被引:32
作者
Abbas, Dina [1 ]
Chong, Erica [1 ]
Raymond, Elizabeth G. [1 ]
机构
[1] Gynu Hlth Projects, New York, NY 10010 USA
关键词
UNITED-STATES; MIFEPRISTONE; MISOPROSTOL; TERMINATION; PREGNANCY; REGIMEN;
D O I
10.1016/j.contraception.2015.06.018
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Data show that an outpatient regimen of 200-mg mifepristone followed by a single dose of misoprostol is safe and effective for medical abortion for up to 70 days from last menstrual period (LMP). Yet, many clinics only provide services up to 63 days LMP, and some practice guidelines do not recommend the higher gestational age limit. We review the studies published to date that include women 64 to 70 days LMP and conclude that outpatient medical abortion is safe and effective in this interval and that there are no clinically meaningful differences between outcomes at 57 to 63 days LMP and 64 to 70 days LMP. Updating clinical protocols and revising the Food and Drug administration label for Mifeprex (R) to change the indication for termination of pregnancies through 70 days LMP will give women more choices and expand access to safe abortion services. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:197 / 199
页数:3
相关论文
共 50 条
[31]   Patient-controlled intravenous versus on-demand oral, intramuscular or mcs intravenous administration of oxycodone during medical induced abortion from 64 to 128 days of Gestation: A randomized controlled trial [J].
Kemppainen, Venla ;
Mentula, Maarit ;
Palkama, Vilja ;
Heikinheimo, Oskari .
CONTRACEPTION, 2022, 115 :6-11
[32]   Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost -: A randomized controlled trial [J].
Dhall, GI ;
Calder, A ;
Gomez-Alzugaray, M ;
Ho, PC ;
Pretnar, AD ;
Chen, JK ;
Bygdeman, M ;
Kovacs, L ;
Kavkasidze, G ;
Song, LJ ;
Van Look, PFA ;
von Hertzen, H ;
Noonan, E ;
Ali, M ;
Peregoudov, A ;
Laperrière, N ;
Grimes, D ;
Ali, M .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2001, 80 (05) :447-451
[33]   Effectiveness and Acceptability of Medical Abortion Provided Through Telemedicine [J].
Grossman, Daniel ;
Grindlay, Kate ;
Buchacker, Todd ;
Lane, Kathleen ;
Blanchard, Kelly .
OBSTETRICS AND GYNECOLOGY, 2011, 118 (02) :296-303
[34]   METHOTREXATE AND MISOPROSTOL FOR ABORTION AT 57-63 DAYS GESTATION [J].
CREININ, MD .
CONTRACEPTION, 1994, 50 (06) :511-515
[35]   Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation [J].
Fox, MC ;
Creinin, MD ;
Harwood, B .
CONTRACEPTION, 2002, 66 (04) :225-229
[36]   The role of parity in medical abortion up to 49 days of amenorrhoea [J].
Lefebvre, Philippe ;
Cotte, Martine ;
Monniez, Nicole ;
Norel, Gerard .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2008, 13 (04) :404-411
[37]   Medical Compared With Surgical Abortion for Effective Pregnancy Termination in the First Trimester [J].
Ireland, Luu Doan ;
Gatter, Mary ;
Chen, Angela Y. .
OBSTETRICS AND GYNECOLOGY, 2015, 126 (01) :22-28
[38]   THE EFFECT OF DOSE OF MIFEPRISTONE AND GESTATION ON THE EFFICACY OF MEDICAL ABORTION WITH MIFEPRISTONE AND MISOPROSTOL [J].
MCKINLEY, C ;
THONG, KJ ;
BAIRD, DT .
HUMAN REPRODUCTION, 1993, 8 (09) :1502-1505
[39]   10-year evaluation of the use of medical abortion through telemedicine: a retrospective cohort study [J].
Norten, H. ;
Ilozumba, O. ;
Wilkinson, J. ;
Gemzell-Danielsson, K. ;
Gomperts, R. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (01) :151-159
[40]   A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation [J].
Murthy, AS ;
Creinin, MD ;
Harwood, B ;
Schreiber, C .
CONTRACEPTION, 2005, 71 (05) :333-336